Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Hepatitis C, 2005 (6)
December, 2005 (1)
- Dendritic cell immunotherapy of hepatitis C virus infection: Toxicology of lipopeptide-loaded dendritic cells.
Jackson DC, Deliyannis G, Eriksson E, Dinatale I, Rizkalla M, Gowans EJ
Int J Peptide Res Ther. 2005 Dec; 11(4):223-235
November, 2005 (1)
- Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection.
Myint KSA, Guan M, Chen HY, Lu Y, Anderson D, Howard T, Noedl H, Mammen MP
Am J Trop Med Hyg. 2005 Nov; 73(5):942-946
May, 2005 (3)
- Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.
Bowden S, McCaw R, White PA, Crofts N, Aitken CK
J Viral Hepat. 2005 May; 12(3):322-324 - Prevalence of antibodies to hepatitis E virus in residents of a district in Havana, Cuba.
Quintana A, Sanchez L, Larralde O, Anderson D
J Med Virol. 2005 May; 76(1):69-70 - Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis e virus in human sera.
Chen HY, Lu Y, Howard T, Anderson D, Fong PY, Hu WP, Chia CP, Guan M
Clin Diagn Lab Immunol. 2005 May; 12(5):593-598
January, 2005 (1)
- A study to investigate the impact of the initiation of highly active antiretroviral therapy on the hepatitis C virus viral load in HIV/HCV-coinfected patients.
Mijch A, Sasadeusz J, Hellard M, Dunne M, McCaw R, Bowden S, Gowans EJ
Antivir Ther. 2005 Jan; 10(2):277-284
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (0)
- Towards Eliminating HIV (0)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (0)
- Maternal, Child and Adolescent Health (0)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (0)
- Eliminate Malaria (0)
- Eliminate Tuberculosis (TB) (0)
- Finance (0)
- Healthy Ageing (0)
- Human Resources (0)
- Burnet Honorary Research Fellows (0)
- Research Support and Facilities (0)
- Harm Reduction (0)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (0)
- Education & Training (0)
- Infectious Diseases Elimination (0)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (0)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (27)
- Sexually Transmitted Infections (STIs) (3)
- Maternal and Child Health (2)
- Immune Disease and Cancer (10)
- Hepatitis B (5)
- Hepatitis C (6)
- Global infectious disease threats (1)
- Injecting Drug Use (4)
